BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 37616559)

  • 1. Cdc73 protects Notch-induced T-cell leukemia cells from DNA damage and mitochondrial stress.
    Melnick AF; Mullin C; Lin K; McCarter AC; Liang S; Liu YE; Wang Q; Jerome NA; Choe E; Kunnath N; Bodanapu G; Akter F; Magnuson B; Kumar S; Lombard DB; Muntean AG; Ljungman M; Sekiguchi J; Ryan RJH; Chiang MY
    Blood; 2023 Dec; 142(25):2159-2174. PubMed ID: 37616559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cdc73 protects Notch-induced T-cell leukemia cells from DNA damage and mitochondrial stress.
    Melnick A; Liang S; Liu Y; Wang Q; Dean N; Choe E; Kunnath N; Bodanapu G; Mullin C; Akter F; Lin K; Magnuson B; Kumar S; Lombard DB; Muntean AG; Ljungman M; Sekiguchi J; Ryan RJH; Chiang MY
    bioRxiv; 2023 Feb; ():. PubMed ID: 36711472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinatorial ETS1-dependent control of oncogenic NOTCH1 enhancers in T-cell leukemia.
    McCarter AC; Della Gatta G; Melnick A; Kim E; Sha C; Wang Q; Nalamolu JK; Liu Y; Keeley TM; Yan R; Sun M; Kodgule R; Kunnath N; Ambesi-Impiombato A; Kuick R; Rao A; Ryan RJH; Kee BL; Samuelson LC; Ostrowski MC; Ferrando AA; Chiang MY
    Blood Cancer Discov; 2020 Sep; 1(2):178-197. PubMed ID: 32924017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The common oncogenomic program of NOTCH1 and NOTCH3 signaling in T-cell acute lymphoblastic leukemia.
    Choi SH; Severson E; Pear WS; Liu XS; Aster JC; Blacklow SC
    PLoS One; 2017; 12(10):e0185762. PubMed ID: 29023469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DDX5 is a positive regulator of oncogenic NOTCH1 signaling in T cell acute lymphoblastic leukemia.
    Lin S; Tian L; Shen H; Gu Y; Li JL; Chen Z; Sun X; You MJ; Wu L
    Oncogene; 2013 Oct; 32(40):4845-53. PubMed ID: 23108395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-range enhancer activity determines Myc sensitivity to Notch inhibitors in T cell leukemia.
    Yashiro-Ohtani Y; Wang H; Zang C; Arnett KL; Bailis W; Ho Y; Knoechel B; Lanauze C; Louis L; Forsyth KS; Chen S; Chung Y; Schug J; Blobel GA; Liebhaber SA; Bernstein BE; Blacklow SC; Liu XS; Aster JC; Pear WS
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):E4946-53. PubMed ID: 25369933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
    Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
    Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch in Leukemia.
    McCarter AC; Wang Q; Chiang M
    Adv Exp Med Biol; 2018; 1066():355-394. PubMed ID: 30030836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAFB enhances oncogenic Notch signaling in T cell acute lymphoblastic leukemia.
    Pajcini KV; Xu L; Shao L; Petrovic J; Palasiewicz K; Ohtani Y; Bailis W; Lee C; Wertheim GB; Mani R; Muthusamy N; Li Y; Meijerink JPP; Blacklow SC; Faryabi RB; Cherry S; Pear WS
    Sci Signal; 2017 Nov; 10(505):. PubMed ID: 29138297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NOTCH1 nuclear interactome reveals key regulators of its transcriptional activity and oncogenic function.
    Yatim A; Benne C; Sobhian B; Laurent-Chabalier S; Deas O; Judde JG; Lelievre JD; Levy Y; Benkirane M
    Mol Cell; 2012 Nov; 48(3):445-58. PubMed ID: 23022380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convergence of the ZMIZ1 and NOTCH1 pathways at C-MYC in acute T lymphoblastic leukemias.
    Rakowski LA; Garagiola DD; Li CM; Decker M; Caruso S; Jones M; Kuick R; Cierpicki T; Maillard I; Chiang MY
    Cancer Res; 2013 Jan; 73(2):930-41. PubMed ID: 23161489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PIAS-like Coactivator Zmiz1 Is a Direct and Selective Cofactor of Notch1 in T Cell Development and Leukemia.
    Pinnell N; Yan R; Cho HJ; Keeley T; Murai MJ; Liu Y; Alarcon AS; Qin J; Wang Q; Kuick R; Elenitoba-Johnson KS; Maillard I; Samuelson LC; Cierpicki T; Chiang MY
    Immunity; 2015 Nov; 43(5):870-83. PubMed ID: 26522984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High selective pressure for Notch1 mutations that induce Myc in T-cell acute lymphoblastic leukemia.
    Chiang MY; Wang Q; Gormley AC; Stein SJ; Xu L; Shestova O; Aster JC; Pear WS
    Blood; 2016 Nov; 128(18):2229-2240. PubMed ID: 27670423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia.
    Sanchez-Martin M; Ferrando A
    Blood; 2017 Mar; 129(9):1124-1133. PubMed ID: 28115368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALL.
    Jeannet R; Mastio J; Macias-Garcia A; Oravecz A; Ashworth T; Geimer Le Lay AS; Jost B; Le Gras S; Ghysdael J; Gridley T; Honjo T; Radtke F; Aster JC; Chan S; Kastner P
    Blood; 2010 Dec; 116(25):5443-54. PubMed ID: 20829372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of MAML1 inhibits proliferation and induces apoptosis of T-cell acute lymphoblastic leukemia cells through SP1-dependent inactivation of TRIM59.
    Cheng H; Chen L; Hu X; Qiu H; Xu X; Gao L; Tang G; Zhang W; Wang J; Yang J; Huang C
    J Cell Physiol; 2019 Apr; 234(4):5186-5195. PubMed ID: 30370525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FHL1C induces apoptosis in Notch1-dependent T-ALL cells through an interaction with RBP-J.
    Fu W; Wang K; Zhao JL; Yu HC; Li SZ; Lin Y; Liang L; Huang SY; Liang YM; Han H; Qin HY
    BMC Cancer; 2014 Jun; 14():463. PubMed ID: 24952875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haploinsufficiency of the c-myc transcriptional repressor FIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1.
    Matsushita K; Kitamura K; Rahmutulla B; Tanaka N; Ishige T; Satoh M; Hoshino T; Miyagi S; Mori T; Itoga S; Shimada H; Tomonaga T; Kito M; Nakajima-Takagi Y; Kubo S; Nakaseko C; Hatano M; Miki T; Matsuo M; Fukuyo M; Kaneda A; Iwama A; Nomura F
    Oncotarget; 2015 Mar; 6(7):5102-17. PubMed ID: 25671302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to resist Notch-targeted T-leukemia therapy: Lineage- and MYC enhancer switch.
    Bayer M; Grosschedl R
    Mol Cell; 2022 Mar; 82(5):884-886. PubMed ID: 35245453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage-specific roles for Zmiz1 in Notch-dependent steps of early T-cell development.
    Wang Q; Yan R; Pinnell N; McCarter AC; Oh Y; Liu Y; Sha C; Garber NF; Chen Y; Wu Q; Ku CJ; Tran I; Serna Alarcon A; Kuick R; Engel JD; Maillard I; Cierpicki T; Chiang MY
    Blood; 2018 Sep; 132(12):1279-1292. PubMed ID: 30076146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.